Dogwood Therapeutics, Inc.

NASDAQ:DWTX

Biotechnology

Healthcare
$1.52 +2.22%

+$0.04 today

Market cap
$51.12M
Beta
1.76
P/E (TTM)
-0.2
EPS (TTM)
-$0.84
52W Low $1.28High $9.50

Volume 0.12M

Average 0.09M

DWTX Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Dogwood Therapeutics, Inc.NASDAQ: DWTX

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity rises 1037.6% from a year ago

Total equity stood at $80.62M at the end of Q1 FY2026, up 1037.6% from a year earlier and up 7.6% from the prior quarter. Over 3 fiscal years it compounded at +117.0% a year.

Context

  • Total equity amounted to 84.7% of total assets at the end of Q1 FY2026, up 77.4 pp from a year earlier.
  • Total equity increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps rising in the next quarterly balance sheet after a +1037.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$80.62M+7.6% QoQ
Last fiscal yearDec 2025
$74.9M+16.5% YoY
Year agoMar 2025
$7.09M+1037.6% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1037.6%——
1 year+16.5%——
3-year CAGR+117.0%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
74.9M USD
Year-over-year change
+16.5%
4-year CAGR
+50.8%

Total Equity vs competitors

How DWTX compares with its peers on the latest reported figures

  • DWTX's Mar 2026 total equity of $80.62M is the highest of the 2 companies compared; the peer median is $10.2M.
  • Its year-over-year change of +1037.6% is the highest of 2, against a peer median of -34.4%.
  • Total equity amounts to 84.7% of total assets for DWTX, versus a peer median of 82.3%.
DWTX Competitors Peer median
Total Equity for DWTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DWTXDogwood Therapeutics, Inc.Mar 2026$80.62M +1037.6%+117.0%84.7%
EDSAEdesa Biotech, Inc.Mar 2026$10.2M -34.4%+9.9%82.3%
Peer median (excluding DWTX) $10.2M-34.4%+9.9%82.3%

Competitors are the stored peer set for DWTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents14.01M7.03M3.32M14.85M6.52M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets8637.29K3.56K28.01K4.88K
Total Current Assets15.78M8.37M4.17M16.54M8.43M
Property, Plant & Equipment (Net)000222.65K194.93K
Goodwill00011.81M12.4M
Intangible Assets00065.71M68.99M
Long-term Investments00018.13K0
Tax Assets00000
Other Non-current Assets0000158.96K
Total Non-current Assets00077.76M81.74M
Total Assets15.78M8.37M4.17M94.31M90.17M
Account Payables353.86K573.16K111.91K1.23M760.95K
Short-term Debt00049.7K0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities532.68K159.7K0687.59K745.08K
Total Current Liabilities1.28M1.04M358.55K3.18M3.06M
Long-term Debt00015.38M0
Deferred Tax Liabilities00011.31M12.11M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities00026.85M12.22M
Total Liabilities1.28M1.04M358.55K30.03M15.27M
Common Stock8331.83K771332.97K
Retained Earnings(43.93M)(56.17M)(61.47M)(73.82M)(108.08M)
Accumulated OCI000(3.86M)(587.04K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity14.5M7.33M3.81M64.28M74.9M
Total Debt00015.59M162.6K
Net Debt(14.01M)(7.03M)(3.32M)737.71K(6.36M)

Dogwood Therapeutics, Inc.

NASDAQ:DWTX

Intrinsic Alpha fair value

Locked

Current Price

$1.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.